These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 19107021)
1. [Bevacizumab and radiotherapy]. Blanchard P; Besse B; Deutsch E Rev Mal Respir; 2008 Dec; 25(10):1319-21. PubMed ID: 19107021 [No Abstract] [Full Text] [Related]
2. Bevacizumab and surgery: what is the real risk? Cohen R; Stebbing J; Windsor A Future Oncol; 2009 Sep; 5(7):915-7. PubMed ID: 19792957 [No Abstract] [Full Text] [Related]
3. Targeted therapies: bevacizumab--has it reached its final resting place? Kerr DJ; Young AM Nat Rev Clin Oncol; 2011 Mar; 8(4):195-6. PubMed ID: 21386819 [No Abstract] [Full Text] [Related]
4. Circulating endothelial cells as biomarkers for patients receiving bevacizumab. Bertolini F; Mancuso P; Shaked Y Lancet Oncol; 2011 Mar; 12(3):217-8. PubMed ID: 21376289 [No Abstract] [Full Text] [Related]
5. Targeting angiogenesis in an age of personalized medicine. Kota GK; Gupta P; Conyers JM; Mintz A Cancer Biol Ther; 2010 Nov; 10(9):874-7. PubMed ID: 21057212 [No Abstract] [Full Text] [Related]
8. Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot. Pivot X Drugs; 2007; 67(12):1800-1. PubMed ID: 17683176 [No Abstract] [Full Text] [Related]
9. Bevacizumab for retinopathy of prematurity. Gilbert CE; Zin A; Darlow B N Engl J Med; 2011 Jun; 364(24):2359-60; author reply 2361-2. PubMed ID: 21675898 [No Abstract] [Full Text] [Related]
10. Bevacizumab: one treatment for all the seasons? Gelibter AJ; Di Segni S; Zeuli M; Cognetti F J Clin Oncol; 2008 Jan; 26(3):511; author reply 511-2. PubMed ID: 18202430 [No Abstract] [Full Text] [Related]
11. Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions. OcaƱa A; Amir E; Vera F; Eisenhauer EA; Tannock IF J Clin Oncol; 2011 Jan; 29(3):254-6. PubMed ID: 21149670 [No Abstract] [Full Text] [Related]
17. Bevacizumab beyond progression: does this make sense? Ellis LM; Haller DG J Clin Oncol; 2008 Nov; 26(33):5313-5. PubMed ID: 18854567 [No Abstract] [Full Text] [Related]
18. Bevacizumab in advanced lung cancer: in search of the right drug for the right patient. Burns TF; Juergens RA Oncology (Williston Park); 2010 Nov; 24(13):1223-4, 1226. PubMed ID: 21192562 [No Abstract] [Full Text] [Related]
19. Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experience. Nieder C; Wiedenmann N; Andratschke NH; Astner ST; Molls M Rev Recent Clin Trials; 2007 Sep; 2(3):163-8. PubMed ID: 18474001 [TBL] [Abstract][Full Text] [Related]